GLYPICAN-3 PROMOTES HEPATOCELLULAR CARCINOMA PROGRESSION AND METASTASIS BY ACTIVATION OF THE ERK SIGNALING PATHWAY

被引：0
|
作者：
Wu, Y. [1 ]
Liu, H. [1 ]
Weng, H. [2 ]
Zhang, X. [1 ]
Li, P. [1 ]
Fan, C. [1 ]
Li, B. [1 ]
Dong, P. [1 ]
Li, L. [1 ]
Dooley, S. [2 ]
Ding, H. [1 ]
机构：
[1] Capital Med Univ, Beijing Youan Hosp, Dept Gastroenterol & Hepatol, Beijing, Peoples R China
[2] Univ Med Ctr Mannheim, Mol Hepatol, Mannheim, Germany
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30537-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0322
引用
收藏
页码：S429 / S430
页数：2
相关论文
共 50 条
  • [31] Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway
    Chan, Kristy Kwan-Shuen
    Leung, Carmen Oi-Ning
    Wong, Carmen Chak-Lui
    Ho, Daniel Wai-Hung
    Chok, Kenneth Siu-Ho
    Lai, Ching-Lung
    Ng, Irene Oi-Lin
    Lo, Regina Cheuk-Lam
    CANCER LETTERS, 2017, 403 : 330 - 338
  • [32] LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway
    Wang, Jianchu
    Luo, Zongjiang
    Yao, Tianwei
    Li, Wenchuan
    Pu, Jian
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (05) : 6908 - 6916
  • [33] Identification of microRNAs controlling Glypican-3 expression in hepatocellular carcinoma
    Maurel, M.
    Ladeiro, Y.
    Jalvy-Delvaille, S.
    Pitard, V.
    Vachet, L.
    Combe, C.
    Sagliocco, F.
    Zucman-Rossi, I.
    Laloo, B.
    Grosset, C.
    BULLETIN DU CANCER, 2011, 98 : S43 - S44
  • [34] Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Horton, Steven
    Noncovich, Alain
    Guest, Matt
    Kim, Daniel
    Salvador, Katrina
    Richardson, Samantha
    Miller, Terra
    Han, Guangzhou
    Bhat, Abhijit
    Song, Kenneth
    Li, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 586 - 592
  • [35] Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
    Kaseb, Ahmed Omar
    Hassan, Manal
    Lacin, Sahin
    Abdel-Wahab, Reham
    Amin, Hesham M.
    Shalaby, Ahmed
    Wolff, Robert A.
    Yao, James
    Rashid, Asif
    Vennapusa, Bharathi
    Feng, Janine
    Ohtomo, Toshihiko
    ONCOTARGET, 2016, 7 (43) : 69916 - 69926
  • [36] Glypican-3: A novel diagnostic marker for hepatocellular carcinoma.
    Sherman, M
    Filmus, J
    Wanless, I
    Capurro, M
    HEPATOLOGY, 2002, 36 (04) : 692A - 692A
  • [37] Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
    Zhou, Fubo
    Shang, Wenting
    Yu, Xiaoling
    Tian, Jie
    MEDICINAL RESEARCH REVIEWS, 2018, 38 (02) : 741 - 767
  • [38] Glypican-3 A Novel Diagnostic Marker for Hepatocellular Carcinoma and More
    Kandil, Dina H.
    Cooper, Kumarasen
    ADVANCES IN ANATOMIC PATHOLOGY, 2009, 16 (02) : 125 - 129
  • [39] ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma
    Kelada, O. J.
    Gutsche, N. T.
    Bell, M.
    Berman, R. M.
    Baidoo, K. E.
    Warner, B. M.
    Szajek, L. P.
    Hong, J.
    Ho, M.
    Choyke, P.
    Escorcia, F. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S180 - S181
  • [40] A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma
    Wu, Qunfeng
    Pi, Liya
    Le, Trinh Thu
    Xia, Chang Qing
    Liu, Chen
    HEPATOLOGY, 2017, 66 : 973A - 973A
12345